We reviewed the role of urodynamics (UDS) in the management of women with incontinence following mid-urethral sling removal (MUSR).
Following IRB approval, women from a longitudinal database who had persistent or recurrent urinary incontinence (UI) after MUSR, desired further therapy, and subsequently underwent UDS were reviewed.
Women with neurogenic bladder, obstructive symptoms without UI, urethra-vaginal fistula, anterior compartment prolapse >Stage 2, or those who had concomitant autologous sling surgery at the time of MUSR were excluded Interval time between MUSR and UDS, UDS findings, and UI management after UDS were recorded
From 2006 to 2013, 71 of 246 women had UDS after MUSR for persistent or recurrent UI For the 54 women in the final analysis, mean time between tape removal and UDS was 12 4 months (range: 4-65) UDS demonstrated incontinence in 78% of patients: stress urinary incontinence (SUI) in 19 (35%), detrusor overactivity incontinence (DOI) in 6 (11%), and mixed urinary incontinence (MUI) in 17 (32%) On pressure-flow studies, the following voiding patterns were demonstrated: normal voiding (39), valsalva voiding (6), obstruction (2), underactive detrusor (1), no voiding records (6) UDS storage and emptying data were used in subsequent symptom-based patient counseling for treatment planning Urethral bulking agent was the most commonly chosen management (43%)
Our current guidelines for UDS in women after incontinence procedures and MUSR are currently based on a low level of evidence This study reinforces the role of UDS to guide therapy for UI after MUSR Neurourol Urodynam © 2015 Wiley Periodicals, Inc
Neurourology and urodynamics 2015 Jul 24 [Epub ahead of print]
Burhan Coskun, Rebecca S Lavelle, Feras Alhalabi, Gary Lemack, Philippe E Zimmern
UT Southwestern Medical Center, Dallas, Texas , UT Southwestern Medical Center, Dallas, Texas , UT Southwestern Medical Center, Dallas, Texas , UT Southwestern Medical Center, Dallas, Texas , UT Southwestern Medical Center, Dallas, Texas